NA Nano Labs Ltd Annual reports only
Semiconductors & Related Devices · Nasdaq · SEC CIK 1872302 · Reporting currency CNY · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-33.5%
TTM net income YoY219.7%
TTM EPS YoY148.5%
Revenue 3-yr CAGR-69.8%
Net income 3-yr CAGR63.3%
Margins
Gross margin-147.3%
Operating margin264.4%
Net margin501.6%
FCF margin-401.1%
EBITDA margin304.9%
Returns
ROE27.7%
ROA15.6%
ROIC (approx.)11.1%
Asset turnover0.03x
Leverage & solvency
Liabilities / assets33.8%
Debt / equity0.24x
Current ratio2.09x
Interest coverage4.21x
Cash quality & payout
Operating cash flow / net income-0.80x
Accruals ratio28.1%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: CNY | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | 27.01M | 40.60M |
| Cost of revenue | 66.80M | 28.99M |
| Gross profit | -39.79M | 11.60M |
| R&D expense | 8.06M | 50.15M |
| SG&A expense | 54.61M | 50.83M |
| Operating income | 71.39M | -114.26M |
| Interest expense | 16.94M | 6.91M |
| Pretax income | 125.95M | -119.54M |
| Net income | 135.47M | -113.19M |
| EBITDA | 82.36M | -104.60M |
| EPS (basic) | 6.82 | -14.06 |
| EPS (diluted) | 6.82 | -14.06 |
| Weighted avg. shares (diluted) | 19.86M | 8.05M |
| Balance sheet | ||
| Cash & equivalents | 8.50M | 32.43M |
| Short-term investments | 26.21M | — |
| Receivables | 281,446 | 572,803 |
| Inventory | 13.69M | 29.87M |
| Current assets | 430.87M | 337.69M |
| PP&E, net | 182.63M | 197.34M |
| Intangibles | 45.76M | 46.75M |
| Total assets | 1.12B | 615.93M |
| Current liabilities | 206.01M | 209.42M |
| Short-term debt | 6.89M | 5.35M |
| Long-term debt | 170.90M | 170.68M |
| Total debt | 177.79M | 176.03M |
| Total liabilities | 378.61M | 383.03M |
| Shareholders' equity | 748.29M | 230.79M |
| Net debt | 169.29M | 143.60M |
| Cash flow statement | ||
| Operating cash flow | -108.27M | -139.33M |
| Capital expenditure | 46,283 | 36.37M |
| Free cash flow | -108.32M | -175.70M |
| Investing cash flow | -296.19M | -256.77M |
| Financing cash flow | 382.39M | 375.98M |
| Depreciation & amortization | 10.96M | 9.66M |
| Stock-based compensation | 73,013 | 401,520 |
| Share buybacks | 1.67M | — |
Free plan shows the latest 2 periods; Pro shows all 6 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· Amounts are in the company's reporting currency, CNY, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.